USA - engelsk - NLM (National Library of Medicine)

alembic pharmaceuticals limited - paclitaxel (unii: p88xt4is4d) (paclitaxel - unii:p88xt4is4d) - paclitaxel injection, usp is indicated as subsequent therapy for the treatment of advanced carcinoma of the ovary. as first-line therapy, paclitaxel injection, usp is indicated in combination with cisplatin. paclitaxel injection, usp is indicated for the adjuvant treatment of node-positive breast cancer administered sequentially to standard doxorubicin-containing combination chemotherapy. in the clinical trial, there was an overall favorable effect on disease-free and overall survival in the total population of patients with receptor-positive and receptor-negative tumors, but the benefit has been specifically demonstrated by available data (median follow-up 30 months) only in the patients with estrogen and progesterone receptor-negative tumors (see clinical studies, breast carcinoma ). paclitaxel injection, usp is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. prior therapy should have included

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

arrow generics ltd - amoxicillin trihydrate - oral capsule - 250mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

arrow generics ltd - amoxicillin trihydrate - oral capsule - 500mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

rx farma - amoxicillin trihydrate - oral capsule - 250mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

rx farma - amoxicillin trihydrate - oral capsule - 500mg

USA - engelsk - NLM (National Library of Medicine)

native remedies, llc - adenosine cyclic phosphate (unii: e0399ozs9n) (adenosine cyclic phosphate - unii:e0399ozs9n), epinephrine (unii: ykh834o4bh) (epinephrine - unii:ykh834o4bh), corticotropin (unii: k0u68q2txa) (corticotropin - unii:k0u68q2txa), hyacinthoides non-scripta (unii: 5f658pfu56) (hyacinthoides non-scripta - unii:5f658pfu56), onion (unii: 492225q21h) (onion - unii:492225q21h), collinsonia canadensis root (unii: o2630f3xdr) (collinsonia canadensis root - unii:o2630f3xdr), cortisone acetate (unii: 883wkn7w8x) ( - adenosine cyclic phosphate 12 [hp_x] in 59 ml - relieves allergies common in the northeastern u.s. uses: for temporary relief of symptoms: itchy, watery eyes, sore throat, cough, runny nose, sneezing, congestion, headaches, hoarseness, and fatigue

USA - engelsk - NLM (National Library of Medicine)

king bio inc. - equal volumes of each hpus ingredient in 12x, 30x, and 1lm potencies., adenosinum cyclophosphoricum, adrenalinum, adrenocorticotrophin (30x), agraphis nutans, allium cepa, arum triphyllum, arundo mauritanica, collinsonia canadensis, cortisone aceticum, euphrasia officinalis, galphimia glauca, histaminum hydrochloricum,kali muriaticum,  natrum muriaticum,  rna,  rumex crispus,  sabadilla,  salvia officinalis,  tanacetum vulgare,  trifolium pratense and  vinca minor., **“hpus” indicates the active ingredients - for temporary relief of allergy symptoms commonly experienced in ct, dc, de, ma, md, me, nh, nj, ny, pa, ri, vt: itchy, watery eyes runny nose sneezing sore throat sinus congestion  cough  stuffy nose  fatigue itchy, irritated skin  hoarseness  headache  † as per various homeopathic materia medicas. claims based on traditional homeopathic practice, not accepted medical evidence. these uses have not been evaluated by the fda, and product has not been clinically tested. reference image: northeastern.jpg  adenosinum cyclophosphoricum..............headache, runny nose adrenalinum ........... hay fever, swollen sinuses, lung congestion adrenocorticotrophin (30x) ............................congestion, cough agraphis nutans ................................... swollen glands or tonsils allium cepa........................hay fever, sinus headache, sneezing arum triphyllum ..........inflammation of nasal mucus membranes arundo mauritanica ........................nasal congestion and itching collinsonia cana

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

luminarie group limited - carmustine 100mg - solution for injection - 100 mg - active: carmustine 100mg excipient: ethanol - bicnu is indicated as palliative therapy as a single agent or in established combination therapy with other approved chemotherapeutic agents in patients with the following malignancies:- 1. primary brain tumours - glioblastoma, brainstem glioma, medulloblastoma, astrocytoma, ependymoma, and metastatic brain tumours. 2. multiple myeloma - in combination with prednisone. 3. menigeal leukaemia - bicnu should be used in patients who have not responded to intrathecal administrations of methotrexate 4. hodgkin's disease - as secondary therapy in combination with other approved drugs in patients who relapse while being treated with primary therapy, or who fail to respond to primary therapy. 5. malignant melanoma (disseminated) - bicnu should be used in combination with other active chemotherapeutic agents. 6. non-hodgkin's lymphomas - as secondary therapy in combination with other approved drugs for patients who relapse while being treated with primary therapy or who fail to respond to primary therapy 7. other solid tumours; gastointestinal carcinoma, breast carcinoma - bicnu has been used in combination with other therapeutic agents only after other conventional methods have failed.

Israel - engelsk - Ministry of Health

pfizer pharmaceuticals israel ltd - crizotinib - capsules - crizotinib 200 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive. xalkori is indicated for the treatment of patients with metastatic nsclc whose tumors are ros1-positive.

Israel - engelsk - Ministry of Health

pfizer pharmaceuticals israel ltd - crizotinib - capsules - crizotinib 200 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive. xalkori is indicated for the treatment of patients with metastatic nsclc whose tumors are ros1-positive.